Filing search / Alkermes plc / "Skills" / Page 2

PREC14A

d3jrghh

8 May 23

Preliminary proxy with contested solicitation

4:34pm

DEFC14A

dzpp lh8e31ok1o

6 Jun 22

Proxy in contested solicitation

5:29pm

PREC14A

oenpyjy7 3t77x3dvil

26 May 22

Preliminary proxy with contested solicitation

5:29pm

DEFA14A

7z9c7n08

16 Feb 22

Additional proxy soliciting materials

7:17am

8-K

EX-99.1

4smwywnrp 4l2l7p

16 Feb 22

Results of Operations and Financial Condition

7:05am

8-K

EX-99.1

zid e6ngsjns

19 Nov 21

Alkermes Announces the Appointment of Cato T. Laurencin, M.D., Ph.D. to its Board of Directors

7:08am

8-K

EX-99.1

onk9fpljicdxvl

1 Jun 21

Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder

7:09am

DEFA14A

EX-99.1

7crkj ogltr

30 Apr 21

Additional proxy soliciting materials

7:11am

8-K

EX-99.1

hragcyr

30 Apr 21

Alkermes Announces Agreement with Sarissa Capital

7:10am

8-K

EX-99.1

64wv6aj78wtt7k w5hv

25 Mar 21

Regulation FD Disclosure

12:00am